Form 4: Acutus Medical Director and Deerfield Management Report Changes in Beneficial Ownership

James E. Flynn, a director by deputization, and Deerfield Management Company, L.P. reported changes in their beneficial ownership of Acutus Medical, Inc. securities, including the termination of warrants and conversion of preferred stock.

Summary

• James E. Flynn, a director by deputization, and Deerfield Management Company, L.P. filed a Form 4 detailing changes in their beneficial ownership of Acutus Medical, Inc. securities.
• The filing includes the reporting of common stock held indirectly through various Deerfield entities.
• The report also details the termination of several warrants to purchase common stock, with the reporting persons receiving $250,000 in consideration.
• Additionally, the filing includes the reporting of Series A Common Stock Equivalent Convertible Preferred Stock, which can be converted into common stock, subject to ownership limitations.
• The transactions occurred on January 27, 2025.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing, and while it includes some financial transactions, it does not indicate a significant positive or negative sentiment. The warrant termination is a neutral event, and the conversion of preferred stock is a standard mechanism.

Positives

• The termination of warrants resulted in a cash payment of $250,000 to the reporting persons.
• The reporting of convertible preferred stock provides insight into potential future common stock ownership.

Negatives

• The termination of warrants suggests a potential reduction in future potential ownership of common stock by the reporting persons.

Risks

• The conversion of preferred stock is subject to ownership limitations, which could impact the timing and extent of future common stock ownership.
• The indirect nature of the holdings through various Deerfield entities adds complexity to the ownership structure.

Future Outlook

The document does not contain any specific forward-looking statements or guidance, but the conversion of preferred stock could lead to future changes in common stock ownership.

Management Comments

• James E. Flynn is the sole member of the general partner of Deerfield Management.
• Andrew ElBardissi, a partner in Deerfield Management, serves as a director of the Issuer.
• The Reporting Persons disclaim beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein.

Industry Context

This filing is a routine disclosure of changes in beneficial ownership by insiders, which is common in the public markets. It provides transparency into the holdings of key stakeholders in Acutus Medical, Inc.

Comparison to Industry Standards

• Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, as mandated by the SEC.
• The reporting of indirect holdings through investment funds is common for institutional investors like Deerfield Management.
• The termination of warrants and conversion of preferred stock are typical transactions that require disclosure in Form 4 filings.
• The level of detail provided in this filing is consistent with SEC requirements for transparency.

Stakeholder Impact

• Shareholders are informed about changes in ownership by key stakeholders.
• The termination of warrants and conversion of preferred stock could impact the future share structure.

Key Dates

Keywords

beneficial ownership, Form 4, Acutus Medical, Deerfield Management, warrants, convertible preferred stock, common stock, insider trading, securities